N/A
Completed N=530
Clinical Characteristics and Microbiology of Healthcare Associated Pneumonia
Healthcare Associated Pneumonia
Source: ClinicalTrials.gov NCT01966796 ↗
Enrolled (actual)
530
Serious AEs
—
Results posted
Sep 2020
Primary outcomePrimary: Pathogens of Healthcare Associated Pneumonia, Measured by the Number of Participants — 15; 51; 195; 269 Participants
Summary
Background The prediction of multi-drug resistant (MDR) pathogens is a key issue in the management of health-care associated pneumonia (HCAP). Multiple risk factors have been proposed, some of which overlap with items of the pneumonia severity index (PSI). The aim of this study was to investigate the relationship between PSI and presence of MDR pathogens.
Methods Patients who were admitted to a tertiary-care hospital from January 2005 to December 2010 were screened by a discharge diagnosis of pneumonia. Patients were enrolled if they fulfilled the definition of HCAP by 2005 ATS/IDSA guideline.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pathogens of Healthcare Associated Pneumonia, Measured by the Number of Participants |
15; 51; 195; 269 | — |
| PRIMARY Number of Participants With MDR Pathogens |
1; 13; 72; 120; 0; 3 | 0.002 sig |
Eligibility Criteria
Inclusion Criteria
- patients who had been hospitalized in an acute care hospital for two or more days within the past 90 days;
- residents of a nursing home or long-term care facility;
- recipients of recent intravenous antibiotic therapy, chemotherapy or wound care within the past 30 days;
- or patients who attended a hospital or hemodialysis clinic.
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT01966796). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.